Patent number: 11964989
Abstract: Compounds that inhibit KRas G12D. In particular, compounds that inhibit the activity of KRas G12D, pharmaceutical compositions comprising the compounds and methods of use therefor, and in particular, methods of treating cancer. The compounds have a general structure represented by Formula (I): or a pharmaceutically acceptable salt thereof.
Type:
Grant
Filed:
July 20, 2022
Date of Patent:
April 23, 2024
Assignees:
Mirati Therapeutics, Inc., Array BioPharma Inc.
Inventors:
Xiaolun Wang, Aaron Craig Burns, James Gail Christensen, John Michael Ketcham, John David Lawson, Matthew Arnold Marx, Christopher Ronald Smith, Shelley Allen, James F. Blake, Mark Joseph Chicarelli, Joshua Ryan Dahlke, Donghua Dai, Jay Bradford Fell, John Peter Fischer, Macedonio J. Mejia, Brad Newhouse, Phong Nguyen, Jacob Matthew O'Leary, Spencer Pajk, Martha E. Rodriguez, Pavel Savechenkov, Tony P. Tang, Guy P.A. Vigers, Qian Zhao, Dean Russell Kahn, John Gaudino, Michael Christopher Hilton
Publication number: 20100070336
Abstract: Methods and apparatus, including systems and computer program products, for a services architecture design that provides enterprise services having customer relationship management functionality at the level of an enterprise application. The design includes a set of service operations, process components, and optionally deployment units. Suitable business objects are also described.
Type:
Application
Filed:
September 18, 2008
Publication date:
March 18, 2010
Inventors:
Alexander Koegler, Hamid Moghaddam, Christian Haas, Berthold Wocher, Steffen Hartig, Joachim Barnbeck, Olivier M. Dreidemy, Alexandra Mark, Michael Lesk, Andre Wachholz-Prill, Martina Lahr, Joerg Walzenbach, Helge Schulte, Volkmar Stegmann, Ingo Pfitzner, Christoph Engler, Wilfried Merkel, Thomas Bach, Cordula Ude, Peer Marschall, Stefan Adelmann, Rainer Heun, Katja Kasteleiner, Martina Keller, Andrea Sudbrack, Anoop Kulkarni, Ralph Meiswinkel, Peter Marx, Simon Dieterich, Matthias Schwarz, Bernhard May